Mental Health Disorders and Determinants among Adolescents Living with HIV: A First National Estimation in Togo (The MIND-HIV Study), 2025
Abstract
BACKGROUND: Depression and anxiety are leading mental health disorders (MHD) among adolescents. Adolescents living with HIV (ALHIV) face distinct challenges such as stigma, social isolation, and psychosocial adversity, which compound their vulnerability to MHD. Despite its significance, data on MHD among ALHIV in Togo remains limited. This study aimed to provide the first national estimate of MHD prevalence and associated factors among ALHIV in Togo. METHODS: A national cross-sectional study was conducted from February to March 2025 across the six health regions of Togo. A stratified multistage random sampling approach was used to recruit ALHIV aged 10–19 years from 25 health facilities. Data collection involved validated psychosocial tools, including the PHQ-9 A for depression, GAD-7 for anxiety, and ULS-8 for loneliness. For prevalence estimation, depression was dichotomized into “Yes” (PHQ-9 score ≥ 10) and “No” (PHQ score < 10). For inferential analysis, depression was categorized into three levels: absent, moderate, and severe. Ordinal and binary logistic regression models were used to identify factors associated with depression and MHD (“combined depression and anxiety”). RESULTS: A total of 542 ALHIV (48.5% females) were included (median age: 15 years). The prevalence of depression among ALHIV was 24.5* with moderate depression observed in 19.9% and severe depression in 4.6%. Anxiety was less prominent, with 0.4% (95%CI: 0.04–1.34%) reporting moderate to severe symptoms. ALHIV experiencing loneliness (aOR: 1.13; 95%CI: 1.06–1.20), stigma (aOR: 4.21; 95%CI: 1.79–9.88), and having coexisting chronic diseases (aOR: 4.09; 95%CI: 1.50-11.16) were more likely to be depressed. Conversely, ALHIV from households earning more than twice the minimum interprofessional wage were significantly less likely to suffer from depression (aOR: 0.25; 95%CI: 0.07–0.91). The same associations were observed for MHD. CONCLUSION: The study highlights a substantial mental health burden among ALHIV in Togo, with depression associated with loneliness, stigma, and comorbidities. Findings emphasize the integration of routine mental health screening into HIV care and tailoring stigma-reduction and economic-support strategies. These results form a critical foundation for national mental health programs addressing ALHIV in Togo.
Related
- Patterns and determinants of formal healthcare utilisation among individuals with and without proxy-identified mental health need in Tanzania: A cross-sectional analysis of the National Panel Survey
- Prevalence of common mental health disorders and associated factors among adolescents and young people living with HIV in Lusaka, Zambia
- Determinants of Adolescent Sexual Behavior in Sub-Saharan Africa: A Systematic Review of In-School and Out-of-School Adolescents
- Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents
- Development and contextual adaptation of the first national clinical practice guideline for autism spectrum disorder in children and adolescents in Tunisia
BibTeX
@article{kanekatoua2026mental,
title = {{Mental Health Disorders and Determinants among Adolescents Living with HIV: A First National Estimation in Togo (The MIND-HIV Study), 2025}},
author = {Sonia Kanekatoua and Arnold Junior Sadio and Fifonsi Adjidossi Gbeasor-Komlanvi and Saliou Salifou and Latifou Assikpa and Aboubakar Issa and Zakillatou Adam and Komlan Mawuko Gbetogbe and Damega Wenkourama and Charfoundine Affo and Adjévi Awoussi and Eddy Yehouenou and René Aklesso Kpeguie and Jean Marie Atsou Alley and Vincent Palokinam Pitche and Didier Koumavi Ekouevi and Simliwa Kolou Dassa and Anoumou Claver Dagnra},
journal = {BMC Psychiatry},
year = {2026},
month = oct,
doi = {10.1186/s12888-025-07488-7},
url = {https://hal.science/hal-05786926v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Mental Health Disorders and Determinants among Adolescents Living with HIV: A First National Estimation in Togo (The MIND-HIV Study), 2025
AU - Sonia Kanekatoua
AU - Arnold Junior Sadio
AU - Fifonsi Adjidossi Gbeasor-Komlanvi
AU - Saliou Salifou
AU - Latifou Assikpa
AU - Aboubakar Issa
AU - Zakillatou Adam
AU - Komlan Mawuko Gbetogbe
AU - Damega Wenkourama
AU - Charfoundine Affo
AU - Adjévi Awoussi
AU - Eddy Yehouenou
AU - René Aklesso Kpeguie
AU - Jean Marie Atsou Alley
AU - Vincent Palokinam Pitche
AU - Didier Koumavi Ekouevi
AU - Simliwa Kolou Dassa
AU - Anoumou Claver Dagnra
PY - 2026
DA - 2026/10/08
JO - BMC Psychiatry
DO - 10.1186/s12888-025-07488-7
UR - https://hal.science/hal-05786926v1
AB - BACKGROUND: Depression and anxiety are leading mental health disorders (MHD) among adolescents. Adolescents living with HIV (ALHIV) face distinct challenges such as stigma, social isolation, and psychosocial adversity, which compound their vulnerability to MHD. Despite its significance, data on MHD among ALHIV in Togo remains limited. This study aimed to provide the first national estimate of MHD prevalence and associated factors among ALHIV in Togo. METHODS: A national cross-sectional study was conducted from February to March 2025 across the six health regions of Togo. A stratified multistage random sampling approach was used to recruit ALHIV aged 10–19 years from 25 health facilities. Data collection involved validated psychosocial tools, including the PHQ-9 A for depression, GAD-7 for anxiety, and ULS-8 for loneliness. For prevalence estimation, depression was dichotomized into “Yes” (PHQ-9 score ≥ 10) and “No” (PHQ score < 10). For inferential analysis, depression was categorized into three levels: absent, moderate, and severe. Ordinal and binary logistic regression models were used to identify factors associated with depression and MHD (“combined depression and anxiety”). RESULTS: A total of 542 ALHIV (48.5% females) were included (median age: 15 years). The prevalence of depression among ALHIV was 24.5* with moderate depression observed in 19.9% and severe depression in 4.6%. Anxiety was less prominent, with 0.4% (95%CI: 0.04–1.34%) reporting moderate to severe symptoms. ALHIV experiencing loneliness (aOR: 1.13; 95%CI: 1.06–1.20), stigma (aOR: 4.21; 95%CI: 1.79–9.88), and having coexisting chronic diseases (aOR: 4.09; 95%CI: 1.50-11.16) were more likely to be depressed. Conversely, ALHIV from households earning more than twice the minimum interprofessional wage were significantly less likely to suffer from depression (aOR: 0.25; 95%CI: 0.07–0.91). The same associations were observed for MHD. CONCLUSION: The study highlights a substantial mental health burden among ALHIV in Togo, with depression associated with loneliness, stigma, and comorbidities. Findings emphasize the integration of routine mental health screening into HIV care and tailoring stigma-reduction and economic-support strategies. These results form a critical foundation for national mental health programs addressing ALHIV in Togo.
SN - 1471-244X
ER -